Market Cap 1.31B
Revenue (ttm) 2.25B
Net Income (ttm) -1.18B
EPS (ttm) N/A
PE Ratio 6.42
Forward PE 5.95
Profit Margin -52.69%
Debt to Equity Ratio 0.90
Volume 766,400
Avg Vol 968,934
Day's Range N/A - N/A
Shares Out 57.56M
Stochastic %K 4%
Beta 1.41
Analysts Strong Sell
Price Target $43.00

Company Profile

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are us...

Industry: Medical Devices
Sector: Healthcare
Phone: 302 252 9160
Address:
2711 Centerville Road, Suite 400, Wilmington, United States
Caliberpi
Caliberpi May. 27 at 4:55 PM
$ENOV šŸ¤¦ā€ā™€ļø
0 Ā· Reply
EmergingMarketDebt
EmergingMarketDebt May. 10 at 5:52 PM
$ENOV Medical-technology company focused on orthopedic and rehabilitation-related healthcare products
0 Ā· Reply
MarketBeat
MarketBeat May. 10 at 8:08 AM
https://marketbeat.com/a/8645045/ $ENOV Enovis Q1 Earnings Call Highlights
0 Ā· Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 10:15 AM
$ENOV Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.15 up 84.69% YoY • Reported revenue of $589.15M up 5.43% YoY • Enovis reaffirms full-year 2026 financial expectations, projecting revenue of $2.31B with 4-6% organic growth, adjusted EBITDA of $425M, and adjusted EPS of $3.52 to $3.73.
0 Ā· Reply
Ren_Stimpy
Ren_Stimpy May. 1 at 11:59 AM
$STIM $BRKR $BIO $AHCO $ENOV this is just a few examples of companies in the medical device industry that sold more of their shares than they currently have. Add up the percentage of institutional, insiders and shares shorted. All well over šŸ’Æ percent!! How will the short sellers buy back shares that don’t exist? I think short sellers are in trouble of losing big betting against this industry.
0 Ā· Reply
fromthesedgegrass
fromthesedgegrass Apr. 25 at 5:46 PM
$ENOV this stock is institution owned to the extent of 98% to 117%. Tells you the pros love this stock
1 Ā· Reply
Puffyk
Puffyk Apr. 17 at 7:37 PM
$ENOV heading to $35 next month
0 Ā· Reply
NakedDayTrader4
NakedDayTrader4 Mar. 11 at 1:53 AM
$ENOV great earnings and analysts upgrades…with price targets $20 dollars higher.,..still cant move this stock. It’s simply unloved
0 Ā· Reply
TI7812
TI7812 Mar. 4 at 6:20 PM
$ENOV good sign stock holding in $25 range during this huge market volatility after the big ER pop from the $22 range. analysts price targets as high as $52 FY26 guide for Adj EPS $3.52 to $3.73 the chart speaks of PMs dumping for like 2 years plus Anyone have a feel for will they be able to meet their guidance?
0 Ā· Reply
SocioCobb
SocioCobb Feb. 26 at 8:41 PM
$ENOV September form 4 (decent size) at $31. This one has room to run higher, imo. In the meantime, here's what I'd look like as a black man šŸ‘€.
0 Ā· Reply
Latest News on ENOV
Enovis Transcript: AGM 2026

May 19, 2026, 12:00 PM EDT - 16 days ago

Enovis Transcript: AGM 2026


Enovis price target raised to $36 from $35 at Evercore ISI

2026-05-08T18:29:43.000Z - 27 days ago

Enovis price target raised to $36 from $35 at Evercore ISI


Enovis price target lowered to $37 from $45 at Baird

2026-05-08T16:43:40.000Z - 27 days ago

Enovis price target lowered to $37 from $45 at Baird


Enovis Earnings Call Transcript: Q1 2026

May 7, 2026, 8:30 AM EDT - 4 weeks ago

Enovis Earnings Call Transcript: Q1 2026


Enovis Earnings release: Q1 2026

May 7, 2026, 8:30 AM EDT - 4 weeks ago

Enovis Earnings release: Q1 2026


Enovis Slides: Q1 2026

May 7, 2026, 8:30 AM EDT - 4 weeks ago

Enovis Slides: Q1 2026


Enovis Quarterly report: Q1 2026

May 7, 2026, 8:30 AM EDT - 4 weeks ago

Enovis Quarterly report: Q1 2026


Enovis reports Q1 adjusted EPS 89c, consensus 81c

2026-05-07T11:34:38.000Z - 4 weeks ago

Enovis reports Q1 adjusted EPS 89c, consensus 81c


Enovis Announces First Quarter 2026 Results

May 7, 2026, 6:01 AM EDT - 4 weeks ago

Enovis Announces First Quarter 2026 Results


Enovis assumed with an Outperform at William Blair

2026-04-17T10:33:10.000Z - 6 weeks ago

Enovis assumed with an Outperform at William Blair


Enovis price target lowered to $39 from $43 at BTIG

2026-04-13T11:52:38.000Z - 7 weeks ago

Enovis price target lowered to $39 from $43 at BTIG


Enovis price target lowered to $35 from $36 at Evercore ISI

2026-04-06T12:21:52.000Z - 2 months ago

Enovis price target lowered to $35 from $36 at Evercore ISI


Enovis Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 2 months ago

Enovis Proxy statement: Proxy filing


Enovis Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 2 months ago

Enovis Proxy statement: Proxy filing


Enovis assumed with an Overweight at Wells Fargo

2026-03-18T10:30:39.000Z - 2 months ago

Enovis assumed with an Overweight at Wells Fargo


Enovis Transcript: 2026 CG Musculoskeletal Conference

Mar 2, 2026, 3:30 PM EST - 3 months ago

Enovis Transcript: 2026 CG Musculoskeletal Conference


Enovis participates in a conference call with JPMorgan

2026-02-27T15:35:19.000Z - 3 months ago

Enovis participates in a conference call with JPMorgan


Enovis Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 3 months ago

Enovis Earnings Call Transcript: Q4 2025


Enovis Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 3 months ago

Enovis Annual report: Q4 2025


Enovis Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 3 months ago

Enovis Earnings release: Q4 2025


Enovis Slides: Q4 2025

Feb 26, 2026, 8:30 AM EST - 3 months ago

Enovis Slides: Q4 2025


Enovis reports Q4 adjusted EPS 95c, consensus 84c

2026-02-26T11:16:04.000Z - 3 months ago

Enovis reports Q4 adjusted EPS 95c, consensus 84c


Enovis sees FY26 adjusted EPS $3.52-$3.73, consensus $3.42

2026-02-26T11:15:13.000Z - 3 months ago

Enovis sees FY26 adjusted EPS $3.52-$3.73, consensus $3.42


Enovis Announces Fourth Quarter and Full Year 2025 Results

Feb 26, 2026, 6:10 AM EST - 3 months ago

Enovis Announces Fourth Quarter and Full Year 2025 Results


Enovis Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 7:30 PM EST - 5 months ago

Enovis Transcript: 44th Annual J.P. Morgan Healthcare Conference


Enovis Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 7:30 PM EST - 5 months ago

Enovis Slides: 44th Annual J.P. Morgan Healthcare Conference


Enovis sees FY25 sales $2.24B-$2.25B, consensus $2.26B

2026-01-12T17:06:35.000Z - 5 months ago

Enovis sees FY25 sales $2.24B-$2.25B, consensus $2.26B


Enovis free cash flow set to improve in FY26, says Evercore ISI

2026-01-12T17:05:58.000Z - 5 months ago

Enovis free cash flow set to improve in FY26, says Evercore ISI


Enovis initiated with a Buy at BTIG

2026-01-06T11:26:47.000Z - 5 months ago

Enovis initiated with a Buy at BTIG


Enovis appoints Oliver Engert chief administrative officer

2026-01-05T21:20:55.000Z - 5 months ago

Enovis appoints Oliver Engert chief administrative officer


Enovis Appoints Oliver Engert as Chief Administrative Officer

Jan 5, 2026, 4:15 PM EST - 5 months ago

Enovis Appoints Oliver Engert as Chief Administrative Officer


Enovis price target lowered to $40 from $44 at Evercore ISI

2026-01-05T14:50:12.000Z - 5 months ago

Enovis price target lowered to $40 from $44 at Evercore ISI


Enovis price target lowered to $50 from $58 at Canaccord

2025-12-17T12:25:11.000Z - 6 months ago

Enovis price target lowered to $50 from $58 at Canaccord


Enovis initiated with a Buy at Freedom Capital

2025-12-16T21:30:15.000Z - 6 months ago

Enovis initiated with a Buy at Freedom Capital


Enovis Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 10:30 AM EST - 7 months ago

Enovis Transcript: Jefferies London Healthcare Conference 2025


Enovis Transcript: UBS Global Healthcare Conference 2025

Nov 10, 2025, 2:45 PM EST - 7 months ago

Enovis Transcript: UBS Global Healthcare Conference 2025


Enovis Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 7 months ago

Enovis Earnings Call Transcript: Q3 2025


Enovis Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 7 months ago

Enovis Quarterly report: Q3 2025


Enovis Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 7 months ago

Enovis Earnings release: Q3 2025


Enovis Slides: Q3 2025

Nov 6, 2025, 8:30 AM EST - 7 months ago

Enovis Slides: Q3 2025


Enovis Announces Third Quarter 2025 Results

Nov 6, 2025, 6:01 AM EST - 7 months ago

Enovis Announces Third Quarter 2025 Results


Enovis Transcript: Baird Global Healthcare Conference 2025

Sep 10, 2025, 2:35 PM EDT - 9 months ago

Enovis Transcript: Baird Global Healthcare Conference 2025


Enovis to Participate in Upcoming Investor Conferences

Aug 8, 2025, 9:00 AM EDT - 10 months ago

Enovis to Participate in Upcoming Investor Conferences


Enovis Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 10 months ago

Enovis Earnings Call Transcript: Q2 2025


Enovis Quarterly report: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 10 months ago

Enovis Quarterly report: Q2 2025


Enovis Earnings release: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 10 months ago

Enovis Earnings release: Q2 2025


Enovis Slides: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 10 months ago

Enovis Slides: Q2 2025


Enovis Announces Second Quarter 2025 Results

Aug 7, 2025, 6:00 AM EDT - 10 months ago

Enovis Announces Second Quarter 2025 Results


Enovis Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Enovis Earnings Call Transcript: Q1 2025


Enovis Quarterly report: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Enovis Quarterly report: Q1 2025


Enovis Earnings release: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Enovis Earnings release: Q1 2025


Enovis Slides: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Enovis Slides: Q1 2025


Enovis Announces First Quarter 2025 Results

May 8, 2025, 6:00 AM EDT - 1 year ago

Enovis Announces First Quarter 2025 Results


Enovis Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Enovis Proxy statement: Proxy Filing


Enovis Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Enovis Proxy statement: Proxy Filing


Enovis Transcript: CG 2025 Musculoskeletal Conference

Mar 10, 2025, 1:00 PM EDT - 1 year ago

Enovis Transcript: CG 2025 Musculoskeletal Conference


Enovis Earnings Call Transcript: Q4 2024

Feb 26, 2025, 8:30 AM EST - 1 year ago

Enovis Earnings Call Transcript: Q4 2024


Enovis Annual report: Q4 2024

Feb 26, 2025, 8:30 AM EST - 1 year ago

Enovis Annual report: Q4 2024


Enovis Earnings release: Q4 2024

Feb 26, 2025, 8:30 AM EST - 1 year ago

Enovis Earnings release: Q4 2024


Enovis Slides: Q4 2024

Feb 26, 2025, 8:30 AM EST - 1 year ago

Enovis Slides: Q4 2024


Enovis Announces Fourth Quarter and Full Year 2024 Results

Feb 26, 2025, 6:01 AM EST - 1 year ago

Enovis Announces Fourth Quarter and Full Year 2024 Results


Enovis Announces Planned CEO Succession Process

Feb 26, 2025, 6:00 AM EST - 1 year ago

Enovis Announces Planned CEO Succession Process


Enovis Slides: FY 2025

Jan 13, 2025, 12:45 PM EST - 1 year ago

Enovis Slides: FY 2025


Enovis Earnings Call Transcript: Q3 2024

Nov 6, 2024, 8:30 AM EST - 1 year ago

Enovis Earnings Call Transcript: Q3 2024


Enovis Quarterly report: Q3 2024

Nov 6, 2024, 8:30 AM EST - 1 year ago

Enovis Quarterly report: Q3 2024


Enovis Earnings release: Q3 2024

Nov 6, 2024, 8:30 AM EST - 1 year ago

Enovis Earnings release: Q3 2024


Enovis Slides: Q3 2024

Nov 6, 2024, 8:30 AM EST - 1 year ago

Enovis Slides: Q3 2024


Enovis Announces Third Quarter 2024 Results

Nov 6, 2024, 6:00 AM EST - 1 year ago

Enovis Announces Third Quarter 2024 Results


Enovis Transcript: 2024 Wells Fargo Healthcare Conference

Sep 5, 2024, 11:00 AM EDT - 1 year ago

Enovis Transcript: 2024 Wells Fargo Healthcare Conference


Enovis Earnings Call Transcript: Q2 2024

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Enovis Earnings Call Transcript: Q2 2024


Enovis Quarterly report: Q2 2024

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Enovis Quarterly report: Q2 2024


Enovis Earnings release: Q2 2024

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Enovis Earnings release: Q2 2024


Enovis Slides: Q2 2024

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Enovis Slides: Q2 2024


Enovis Announces Second Quarter 2024 Results

Aug 7, 2024, 6:00 AM EDT - 1 year ago

Enovis Announces Second Quarter 2024 Results


Enovis Transcript: BofA Securities 2024 Health Care Conference

May 15, 2024, 7:20 PM EDT - 2 years ago

Enovis Transcript: BofA Securities 2024 Health Care Conference


Enovis Earnings Call Transcript: Q1 2024

May 2, 2024, 8:00 AM EDT - 2 years ago

Enovis Earnings Call Transcript: Q1 2024


Enovis Quarterly report: Q1 2024

May 2, 2024, 8:00 AM EDT - 2 years ago

Enovis Quarterly report: Q1 2024


Enovis Earnings release: Q1 2024

May 2, 2024, 8:00 AM EDT - 2 years ago

Enovis Earnings release: Q1 2024


Enovis Slides: Q1 2024

May 2, 2024, 8:00 AM EDT - 2 years ago

Enovis Slides: Q1 2024


Enovis Announces First Quarter 2024 Results

May 2, 2024, 6:00 AM EDT - 2 years ago

Enovis Announces First Quarter 2024 Results


Enovis Proxy statement: Proxy Filing

Apr 5, 2024, 8:00 AM EDT - 2 years ago

Enovis Proxy statement: Proxy Filing


Enovis Proxy statement: Proxy Filing

Apr 5, 2024, 8:00 AM EDT - 2 years ago

Enovis Proxy statement: Proxy Filing


Enovis Proxy statement: Proxy Filing

Mar 25, 2024, 8:00 AM EDT - 2 years ago

Enovis Proxy statement: Proxy Filing


Enovis Earnings Call Transcript: Q4 2023

Feb 22, 2024, 8:30 AM EST - 2 years ago

Enovis Earnings Call Transcript: Q4 2023


Enovis Annual report: Q4 2023

Feb 22, 2024, 8:30 AM EST - 2 years ago

Enovis Annual report: Q4 2023


Enovis Earnings release: Q4 2023

Feb 22, 2024, 8:30 AM EST - 2 years ago

Enovis Earnings release: Q4 2023


Enovis Slides: Q4 2023

Feb 22, 2024, 8:30 AM EST - 2 years ago

Enovis Slides: Q4 2023


Enovis Announces Fourth Quarter and Full Year 2023 Results

Feb 22, 2024, 6:00 AM EST - 2 years ago

Enovis Announces Fourth Quarter and Full Year 2023 Results


Enovis Introduces the DonJoy ROAMā„¢ OA Knee Brace

Jan 25, 2024, 8:30 AM EST - 2 years ago

Enovis Introduces the DonJoy ROAMā„¢ OA Knee Brace


Enovis Slides: FY 2024

Jan 8, 2024, 12:45 PM EST - 2 years ago

Enovis Slides: FY 2024


Enovis Completes Acquisition of LimaCorporate S.p.A

Jan 3, 2024, 6:00 AM EST - 2 years ago

Enovis Completes Acquisition of LimaCorporate S.p.A


Enovis Announces Business Segment Leadership Transition Plan

Dec 5, 2023, 6:00 AM EST - 2 years ago

Enovis Announces Business Segment Leadership Transition Plan


Enovis Earnings Call Transcript: Q3 2023

Nov 7, 2023, 8:00 AM EST - 2 years ago

Enovis Earnings Call Transcript: Q3 2023


Enovis Quarterly report: Q3 2023

Nov 7, 2023, 8:00 AM EST - 2 years ago

Enovis Quarterly report: Q3 2023


Enovis Earnings release: Q3 2023

Nov 7, 2023, 8:00 AM EST - 2 years ago

Enovis Earnings release: Q3 2023


Enovis Slides: Q3 2023

Nov 7, 2023, 8:00 AM EST - 2 years ago

Enovis Slides: Q3 2023


Caliberpi
Caliberpi May. 27 at 4:55 PM
$ENOV šŸ¤¦ā€ā™€ļø
0 Ā· Reply
EmergingMarketDebt
EmergingMarketDebt May. 10 at 5:52 PM
$ENOV Medical-technology company focused on orthopedic and rehabilitation-related healthcare products
0 Ā· Reply
MarketBeat
MarketBeat May. 10 at 8:08 AM
https://marketbeat.com/a/8645045/ $ENOV Enovis Q1 Earnings Call Highlights
0 Ā· Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 10:15 AM
$ENOV Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.15 up 84.69% YoY • Reported revenue of $589.15M up 5.43% YoY • Enovis reaffirms full-year 2026 financial expectations, projecting revenue of $2.31B with 4-6% organic growth, adjusted EBITDA of $425M, and adjusted EPS of $3.52 to $3.73.
0 Ā· Reply
Ren_Stimpy
Ren_Stimpy May. 1 at 11:59 AM
$STIM $BRKR $BIO $AHCO $ENOV this is just a few examples of companies in the medical device industry that sold more of their shares than they currently have. Add up the percentage of institutional, insiders and shares shorted. All well over šŸ’Æ percent!! How will the short sellers buy back shares that don’t exist? I think short sellers are in trouble of losing big betting against this industry.
0 Ā· Reply
fromthesedgegrass
fromthesedgegrass Apr. 25 at 5:46 PM
$ENOV this stock is institution owned to the extent of 98% to 117%. Tells you the pros love this stock
1 Ā· Reply
Puffyk
Puffyk Apr. 17 at 7:37 PM
$ENOV heading to $35 next month
0 Ā· Reply
NakedDayTrader4
NakedDayTrader4 Mar. 11 at 1:53 AM
$ENOV great earnings and analysts upgrades…with price targets $20 dollars higher.,..still cant move this stock. It’s simply unloved
0 Ā· Reply
TI7812
TI7812 Mar. 4 at 6:20 PM
$ENOV good sign stock holding in $25 range during this huge market volatility after the big ER pop from the $22 range. analysts price targets as high as $52 FY26 guide for Adj EPS $3.52 to $3.73 the chart speaks of PMs dumping for like 2 years plus Anyone have a feel for will they be able to meet their guidance?
0 Ā· Reply
SocioCobb
SocioCobb Feb. 26 at 8:41 PM
$ENOV September form 4 (decent size) at $31. This one has room to run higher, imo. In the meantime, here's what I'd look like as a black man šŸ‘€.
0 Ā· Reply
NakedDayTrader4
NakedDayTrader4 Feb. 26 at 3:16 PM
$ENOV excellent qtr and raised guidance. I have no idea why this got beaten down so bad the past month or two. It’s a money making machine in a fast growing sector.
1 Ā· Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 26 at 11:29 AM
$ENOV Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$9.10 up 27.95% YoY • Reported revenue of $575.76M up 2.64% YoY • Enovis expects 2026 revenue of $2.31B, with 4-6% organic growth. Adjusted EBITDA is projected at $425M, and adjusted EPS is anticipated to be $3.52 to $3.73.
0 Ā· Reply
Abdul92z
Abdul92z Feb. 7 at 12:46 PM
$PATH & $ENOV šŸ‘€
0 Ā· Reply
AccountAscender
AccountAscender Feb. 4 at 2:17 PM
$ENOV is a provider of software and services for product lifecycle management; it operates in a niche market with stable demand from manufacturing clients.
0 Ā· Reply
The_Trading_Mechanic
The_Trading_Mechanic Jan. 30 at 12:50 PM
ENOVis trading at major long-term support, sitting near levels last seen during the 2020 lows and areas that previously acted as key support during the 2009 cycle. These zones represent historically significant demand areas where buyers have stepped in before. A decisive push through the $29.00 level would confirm a trend shift and open the door for a move toward the $37.98 resistance, offering strong upside from current prices. With a clearly defined stop loss at $20.00, this setup presents an excellent risk-to-reward ratio, making ENOV an attractive rebound and value recovery play. If you enjoy my analysis and want to see more trade ideas like this, your support means the world to me! Consider liking, sharing, or following for more deep dives into market opportunities.
0 Ā· Reply
stockRDA
stockRDA Jan. 28 at 11:33 PM
$ENOV this starting to hurt right now….
0 Ā· Reply
NakedDayTrader4
NakedDayTrader4 Jan. 28 at 4:37 PM
$ENOV shorts having their way with this
1 Ā· Reply
NakedDayTrader4
NakedDayTrader4 Jan. 20 at 10:55 PM
$ENOV I stand corrected, I’m now convinced we’re never going up againšŸ˜‚
1 Ā· Reply
NakedDayTrader4
NakedDayTrader4 Jan. 20 at 12:42 AM
$ENOV guess we’ll lose another 5% tomorrow..on top of the 20% we lost in just the past 5 trading days. Ridiculous.
1 Ā· Reply
stockRDA
stockRDA Jan. 16 at 9:54 PM
$ENOV valuation is absurd.
0 Ā· Reply